These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4150557)

  • 1. Proceedings: The effect of formulation on the availability of sulphadiazine.
    Garnham JC; Raymond K; Shotton E; Turner P
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:151P-152. PubMed ID: 4150557
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of magnesium stearate on the dissolution and biological availability of sulphadiazine tablet formulations [proceedings].
    Ahmed M; Enever RP
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():5P. PubMed ID: 12326
    [No Abstract]   [Full Text] [Related]  

  • 3. [Formulation of tablets and bioavailability: a biologic method of evaluation].
    Lévy-Appert-Collin M; Willemin JC; Lévy J
    Pharm Acta Helv; 1976; 51(11):348-51. PubMed ID: 1019179
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in tablet technology.
    Cooper J
    Adv Pharm Sci; 1971; 3():1-106. PubMed ID: 4947390
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the physiological availability and metabolism of sulfonamides. I. Sulfadiazine.
    Van Petten GR; Becking GC; Withey RJ; Lettau HF
    J Clin Pharmacol New Drugs; 1971; 11(1):27-34. PubMed ID: 4926393
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biopharmaceutics and drug formulation].
    Riccieri FM
    Ann Ist Super Sanita; 1982; 18(3):541-6. PubMed ID: 7187842
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 2. Effect of disintegrants.
    Asker A; el-Nakeeb M; Motawi M; el-Gindy N
    Pharmazie; 1973 Jul; 28(7):474-6. PubMed ID: 4767500
    [No Abstract]   [Full Text] [Related]  

  • 9. [Formulation of tablets with the aid of chain extentiometry. I. Technics of the study].
    Delacourte-Thibaut A; Devise B; Guyot JC; Traisnel M
    J Pharm Belg; 1974; 29(3):251-80. PubMed ID: 4422209
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the physiological availability and metabolism of sulfonamides. 3. Triple sulfa.
    Withey RJ; Van Petten GR; Lettau HF
    J Clin Pharmacol New Drugs; 1972; 12(5):190-5. PubMed ID: 4555877
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of mixing on the biopharmaceutical properties of sulfadiazine tablets.
    Morasso MI; Salas J; Arancibia A
    Farmaco Prat; 1988 May; 43(5):177-88. PubMed ID: 3181415
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum concentrations of trimethoprim and sulfadiazine following oral paste administration to the horse.
    Sigel CW; Byars TD; Divers TJ; Murch O; DeAngelis D
    Am J Vet Res; 1981 Nov; 42(11):2002-5. PubMed ID: 7337298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
    Tomassini L; Naplatanova D
    Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of a calf salmonellosis model to evaluate the therapeutic properties of trimethoprim and sulphadiazine and their mutual potentiation in vivo.
    White G; Piercy DW; Gibbs HA
    Res Vet Sci; 1981 Jul; 31(1):27-31. PubMed ID: 7313315
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Influence of formulation on absorption and clinical effect of digoxin.
    Shaw TR; Howard MR; Hamer J
    Br Heart J; 1974 Apr; 36(4):400. PubMed ID: 4841478
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of sulphadiazine, trimethoprim and metronidazole or tinidazole in kala-azar.
    Bano P; Shahab SM
    J Assoc Physicians India; 1994 Jul; 42(7):535-6. PubMed ID: 7868522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for short term drug absorption studies; comparison of sulphadiazine tablets.
    Saunders L; Ahmed M; Enever RP; Natunen T
    J Pharm Pharmacol; 1978 Jan; 30(1):11-4. PubMed ID: 22718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of tetroxoprim and sulphadiazine in human volunteers.
    Reeves DS; Broughall JM; Bywater MJ; Holt HA; Vergin H
    J Antimicrob Chemother; 1979 Nov; 5(B):119-38. PubMed ID: 536337
    [No Abstract]   [Full Text] [Related]  

  • 20. Scheele lecture. Biopharmaceutical aspects of drug formulation.
    Davis SS
    Acta Pharm Suec; 1986; 23(5):305-14. PubMed ID: 3565033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.